Nivolumab + Docetaxel + ADT in mHSPC Patients With DDRD or Inflamed Tumors

Clinical trial NCT04126070 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04126070
Sponsor: Xiao X. Wei, MD
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Hormone Sensitive Prostate Cancer Prostate Adenocarcinoma Metastasis Prostate Adenocarcinoma

Start date: 2020-05-11
Primary completion: 2025-07-29
Enrollment: 47

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.